Laura Stoppel's most recent trade in Artiva Biotherapeutics Inc was a trade of 13,750 Director Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Artiva Biotherapeutics Inc | Laura Stoppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 13,750 | 13,750 | - | - | Director Stock Option (Right to Buy) | |
| Acumen Pharmaceuticals Inc | Laura Stoppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 19,500 | 19,500 | - | - | Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Laura Stoppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 12,800 | 12,800 | - | 0 | Common Stock | |
| Acumen Pharmaceuticals Inc | Laura Stoppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Laura Stoppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Laura Stoppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Laura Stoppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) |